Piquin 7.5 Tablet contains Primaquine 7.5mg, an antimalarial agent specifically used for the radical cure of malaria caused by Plasmodium vivax and Plasmodium ovale. It helps in eliminating dormant liver-stage parasites, thereby reducing the risk of malaria relapse.
Primaquine acts by targeting hypnozoites present in the liver, which are responsible for recurrent malaria infections. By completing the full treatment course, it supports long-term malaria control and enhances treatment effectiveness when used alongside blood schizonticidal agents.
For distributors and healthcare suppliers, Piquin 7.5 Tablet is a critical antimalarial therapy product, commonly supplied to hospitals, government healthcare programs, clinics, and endemic regions. Seasonal malaria outbreaks and public health initiatives contribute to sustained demand.
Adding Piquin 7.5 Tablet to your antimalarial and infectious disease segment creates strong opportunities in pharmacy supply, hospital procurement, export markets, and third-party manufacturing. Its essential role in malaria eradication strategies makes it a valuable and reliable product in pharmaceutical distribution portfolios.